Literature DB >> 309436

Mitogenicity of Mycoplasma fermentans for human lymphocytes.

E Nilsson.   

Abstract

The in vitro stimulation response of human lymphocytes to Mycoplasma fermentans was examined. M. fermentans stimulated DNA synthesis in blood lymphocytes from all of 20 healthy subjects examined. Only one of these subjects had complement-fixing antibodies to M. fermentans. Lymphocytes from 21 of 22 adenoids and from 1 spleen were also stimulated to DNA synthesis by M. fermentans. The organism induced DNA synthesis in both B and T lymphocytes from adenoids and spleen and preferentially in T lymphocytes from blood. M. fermentans was shown to activate adenoid lymphocytes to non-amtogem-specific antibody secretion demonstrable by a hemolytic plaque assay. It is concluded that M. fermentans can have a mitogenic effect on both B and T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309436      PMCID: PMC421955          DOI: 10.1128/iai.21.1.48-54.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  SRBC rosette formation as a human T lymphocyte marker.

Authors:  M Jondal
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

2.  SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOOD.

Authors:  A S COULSON; D G CHALMERS
Journal:  Lancet       Date:  1964-02-29       Impact factor: 79.321

Review 3.  MYCOPLASMA SPECIES OF MAN.

Authors:  L HAYFLICK; R M CHANOCK
Journal:  Bacteriol Rev       Date:  1965-06

4.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

Authors:  R M CHANOCK; L HAYFLICK; M F BARILE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

5.  Effect of A. laidlawii on murine and human lymphocyte cultures.

Authors:  H Kirchner; H Brunner; H Rühl
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

6.  Comparison of the pyrogenicity, Limulus activity mitogenicity and complement reactivity of several bacterial endotoxins and related compounds.

Authors:  R J Elin; A L Sandberg; D L Rosentreich
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

7.  Mycoplasma-dependent activation of normal lymphocytes: mitogenic potential of mycoplasmas for mouse lymphocytes.

Authors:  B C Cole; K E Aldridge; J R Ward
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

8.  Detection of serum proteins in the electrophoretic patterns of total proteins of mycoplasma cells.

Authors:  O E Yaguzhinskaya
Journal:  J Hyg (Lond)       Date:  1976-10

9.  Activation of human lymphocyte subpopulations by Mycoplasma pneumoniae.

Authors:  G Biberfeld
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Lymphocyte activation by various Mycoplasma strains and species.

Authors:  Y Naot; J G Tully; H Ginsburg
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

View more
  4 in total

1.  Genotypic and phenotypic analysis of Mycoplasma fermentans strains isolated from different host tissues.

Authors:  L Campo; P Larocque; T La Malfa; W D Blackburn; H L Watson
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

2.  Antigenic mimicry of mammalian intermediate filaments by mycoplasmas.

Authors:  K S Wise; R K Watson
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

3.  In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals.

Authors:  Y Sasaki; A Blanchard; H L Watson; S Garcia; A Dulioust; L Montagnier; M L Gougeon
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

4.  Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans.

Authors:  S H Feng; S C Lo
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.